Evidence map›Paper›PMID 42271140›Full record

ArticleNPJ digital medicine2026

Benchmarking deep learning architectures for MALDI-TOF mass spectrometry in infectious disease diagnostics and vector-borne disease surveillance.

Noshine Mohammad, Alexandre Godmer, Renaud Piarroux, Cécile Nabet, Xavier Tannier

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Noshine MohammadInstitut Pierre-Louis d'Epidémiologie et de Santé Publique, Inserm, IPLESP, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Parasitologie-Mycologie, Sorbonne Université, Paris, France. noshine.mohammad@gmail.com.
Alexandre GodmerSorbonne Université, CNRS, INSERM, Centre d'Immunologie et des Maladies Infectieuses (CIMI), Paris, France.
Renaud PiarrouxInstitut Pierre-Louis d'Epidémiologie et de Santé Publique, Inserm, IPLESP, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Parasitologie-Mycologie, Sorbonne Université, Paris, France.
Cécile NabetInstitut Pierre-Louis d'Epidémiologie et de Santé Publique, Inserm, IPLESP, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Parasitologie-Mycologie, Sorbonne Université, Paris, France.
Xavier TannierSorbonne Université, Université Sorbonne Paris Nord, INSERM, LIMICS FR, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging global health threats, from antimicrobial resistance to vector-borne diseases, require scalable diagnostic solutions. Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry has revolutionized microbial diagnostics but remains underutilized in public health due to algorithmic challenges in interpreting and generalizing complex spectra. Here, we present a systematic benchmarking framework to expand MALDI-TOF's utility for field-deployable diagnostics using diverse deep learning architectures and preprocessing strategies, including approaches newly applied to spectral data. Using a total of 7424 mass spectra from clinical and field-collected datasets, we evaluated Mycobacterium abscessus subspecies and antimicrobial resistance classification (814 training/187 test spectra from 33/8 isolates); Anopheles mosquito species identification across anatomical parts (legs: 1047/188 spectra from 211/40 specimens; head: 1089/214 spectra; thorax: 999/279 spectra); and mosquito age estimation (legs: 806/144 spectra from 202/36 specimens; head: 727/124 spectra; thorax: 689/117 spectra). Results demonstrate that balanced accuracy ranged from 84% to 95% for species/subspecies identification and from 91% to 99% for resistance prediction, and that mean absolute error ranged from 1.9 to 3.8 days for age estimation. Key to this performance are adaptations managing instrumental and biological variability. We further assess computational efficiency and energy consumption, highlighting trade-offs between accuracy and deployment feasibility. These findings support AI-enhanced MALDI-TOF as a practical tool for global health surveillance and precision diagnostics in resource-limited settings.

Identifiers

PMID42271140
PMCPMC13597518

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.